Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model-Reference-Cited by-同舟云学术

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model

Published:2022-07-08 Issue:13 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Rosenke Kyle,Okumura Atsushi^ORCID,Lewis Matthew C.^ORCID,Feldmann Friederike,Meade-White Kimberly,Bohler W. Forrest,Griffin Amanda,Rosenke Rebecca^ORCID,Shaia Carl^ORCID,Jarvis Michael A.^ORCID,Feldmann Heinz^ORCID

Funder

NIAID, NIH

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/160108/files/pdf

Reference30 articles.

1. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

2. European Medicines Agency. Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant. https://www.ema.europa.eu/en/news/preliminary-data-indicate-covid-19-vaccines-remain-effective-against-severe-disease-hospitalisation Accessed May 31, 2022

3. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

4. Lyngse FP, et al. SARS-CoV-2 Omicron VOC transmission in Danish households [preprint]. https://doi.org/10.1101/2021.12.27.21268278 Posted on medRix December 27, 2021

5. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

2. New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses;Antiviral Research;2024-05

3. Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns;Heliyon;2024-05

4. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

5. Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens;iScience;2024-03